Alcohol s Impact on HIV Incidence, Treatment Adherence, and Health Outcomes
|
|
- Vernon Wilkinson
- 5 years ago
- Views:
Transcription
1 Alcohol s Impact on HIV Incidence, Treatment Adherence, and Health Outcomes Paul A. Shuper, Ph.D. 1,2,3,4 October 24, Senior Scientist Centre for Addiction and Mental Health Toronto, Ontario, Canada 2 Assistant Professor Department of Psychology University of Toronto; Toronto, Ontario, Canada 3 Affiliate Institute for Collaboration on Health, Intervention, and Policy University of Connecticut; Storrs, CT, USA 4 Associate Member of Staff Alcohol, Tobacco and other Drug Research Unit South African Medical Research Council Pretoria, South Africa
2 Presenter Disclosure Presenter: Paul Shuper, Ph.D. Relationships with Commercial Interests Grants/Research Support: CIHR, OHTN, NIH (NIMH, NIAAA), SA MRC, PAHO Speakers Honoraria: WHO (reimbursement for travel expenses only) NIAAA (reimbursement for travel expenses only) Consulting Fees: None (see above reimbursement for travel) Other: Employee of CAMH
3
4 Alcohol and HIV Acquisition/Transmission
5 Alcohol and Condomless Sex
6 Evidence for an Alcohol- Condomless Sex Association Systematic Reviews and Meta-analyses Sub-Saharan Africa (e.g., Kalichman et al., 2007; Kiene et al., 2013; Woolf & Maisto, 2011) China (Li et al., 2010) Gay and bisexual men (e.g., Woolf & Maisto, 2009; Heath et al., 2011) University students (e.g., Cooper, 2002; Leigh, 2002) HIV-positive populations (e.g., Shuper et al., 2009)
7 Alcohol s Causal Role in Condomless Sex?
8 Alcohol and Condomless Sex Intentions: Controlled Laboratory Experiments Alcohol Placebo Hypothetical Scenarios Intentions to Use Condoms Shuper et al., (2016)
9 Alcohol and Condomless Sex Intentions: Meta-Analyses Rehm, Shield, Joharchi, & Shuper (2012) Scott-Sheldon et al. (2016) Findings and Conclusions Alcohol directly causes condomless sex intentions Effect is increased with sexual arousal Alcohol results in weaker communication/ condom negotiation skills
10 Alcohol and HIV Incidence
11 Alcohol and HIV Incidence: Meta-Analysis of Prospective Studies Methods Comprehensive literature review prospective studies on HIV incidence Results 873 articles identified 10 studies yielded Baliunas, Rehm, Irving, & Shuper (2010)
12 Alcohol and HIV Incidence: Meta-Analysis of Prospective Studies Results: Any alcohol consumption Effect % Author & Year size (95% CI) Weight Koblin (1.22, 2.09) Kapiga (1.54, 3.82) Page-Shafer (0.90, 3.45) Celentano (0.61, 4.85) 4.27 Overall 1.78 (1.43, 2.20) Relative risk Baliunas, Rehm, Irving, & Shuper (2010)
13 Alcohol and HIV Incidence: Meta-Analysis of Prospective Studies Results: Binge drinking Effect % Author & Year size (95% CI) Weight Plankey (0.81, 1.56) Read (1.10, 11.40) Koblin (1.32, 2.96) Nopkesorn (1.00, 10.90) Chesney (2.42, 3.88) Overall 2.20 (1.29, 3.74) Relative risk Baliunas, Rehm, Irving, & Shuper (2010)
14 Alcohol and HIV Incidence: Meta-Analysis of Prospective Studies Results: Alcohol consumption prior to sex Effect % Author & Year size (95% CI) Weight Read (1.05, 6.28) 9.59 Zablotska (1.51, 2.09) Figueroa (1.53, 31.00) 3.68 Clentano (0.91, 2.58) Overall 1.86 (1.39, 2.51) Relative risk Baliunas, Rehm, Irving, & Shuper (2010)
15 Alcohol Consumption and HIV Treatment
16 Alcohol and the HIV Treatment Cascade See Reviews from Azar et al. (2010) and Vagenas et al. (2015)
17 Alcohol Consumption and HIV Diagnosis
18 Alcohol and HIV Diagnosis Vagenas, Ludford, Gonzales, et al. (2014) Biobehavioural survey of 5,148 MSM in Peru Alcohol assessment; HIV testing Results HIV+ N=420 (8.2%) 57% AUD Status Aware N=43 (10.2%) Status Unaware N=377 (89.8%)
19 Alcohol Consumption and Retention in Care
20 Alcohol and Retention in Care Pecoraro, Mimiaga, O'Cleirigh,et al. (2015) 240 PLWH in St. Petersburg, Russia Examined factors associated with loss-to-care (nonattendance in ART care for > 12 months) Results Drinking alcohol past 30 days ~3X risk of loss-to-care 63% reported drug and/or alcohol use as reason for attrition
21 Alcohol Consumption and ART Adherence
22 Potential Pathways Linking Alcohol with ART Non-Adherence? Cognitive impairment Decreased access to ART; Poorer retention in care (e.g., Tucker et al., 2004) Inaccurate perceptions cannot take ART if drinking (Kalichman et al., 2009; 2012)
23 Evidence for an Alcohol - Non-Adherence Association
24 Meta Analysis: Alcohol and ART Adherence Methods Comprehensive literature review and meta-analysis Studies reporting associations between alcohol use and ART adherence Results 259 articles yielded 40 studies Hendershot et al., 2009
25 Meta Analysis: Alcohol and ART Adherence Alcohol Categorization Alcohol Users/ Consumption vs. Non-Users/ Consumption Problem Drinkers vs. Non-Problem Drinkers/Abstainers Moderate Drinkers vs. Abstainers/ Consumption Any use vs. No-use (past year) Result OR (95% CI) 0.55 ( ) 0.47 ( ) 0.48 ( ) 0.60 ( ) Hendershot et al., 2009
26 Evidence for a Causal Alcohol- Non-Adherence Association? Temporal and Dose-Response Associations
27 Braithwaite et al Methods Telephone surveys with >2000 participants (US) alcohol consumed; missed doses Results: Among drinkers: 4% missed doses on non-drinking days 6% missed doses on drinking days (without binge) 14% missed doses on binge drinking days Braithwaite et al., 2005
28 Parsons, Rosof, & Mustanski, 2008 Methods 272 (US) HIV+ with alcohol problems Alcohol consumed, ART doses taken Regimen complexity Results On days during which alcohol was consumed ~9X increased likelihood of non-adherence (OR=8.8, CI= ) Each drink increased the odds of non-adherence by 20% (OR=1.20, CI= ) Parsons et al., 2008
29 Regimen Less Complex More Complex
30 De Boni et al Temporal Relationship between Alcohol and ART Adherence Method 255 PLWH in LMICs Weekday vs. weekend adherence Binge drinking occasions
31 De Boni, Zheng, Rosenkranz, et al Temporal Relationship between Alcohol and ART Adherence Weekending
32 Alcohol Consumption and Treatment Outcomes
33 Alcohol and Treatment Outcomes Kader, Seedat, Govender, et al. (2015) 1,503 PLWH attending South African HIV clinics Predictors of CD4 count
34 Alcohol and Treatment Outcomes Diess, Mesner, Agan, et al. (2016) 752 HIV+ US military personnel - US Military Natural History Study Predictors of virologic failure (2 consecutive VL measurements>200 copies/ml, 6 months post ART initiation)
35 Summary and Implications
36 Williams, Hahn, Saitz, et al., 2016
37 Summary and Implications Individual-level interventions Alcohol screening and counselling targeted populations Combined initiatives Structural interventions HIV prevention in alcohol establishments Condom availability, outreach counselling/testing, peer leaders, prevention cues Government Alcohol taxation, availability, and marketing
38 Questions? Contact details: Paul A. Shuper, Ph.D. Centre for Addiction and Mental Health 33 Russell Street Toronto, ON, M5S 2S1, Canada Office: , ext Fax:
Alcohol, Infectious Diseases and Gender-based Violence Context Setting and Overview of Policy and Programme Responses
Alcohol, Infectious Diseases and Gender-based Violence Context Setting and Overview of Policy and Programme Responses V. Poznyak, MD, PhD Coordinator, Management of Substance Abuse Department of Mental
More informationHIV Endgame II: Stopping the Syndemics that Drive HIV
Sean B. Rourke, Ph.D., FCAHS Scientific and Executive Director, OHTN Professor of Psychiatry, University of Toronto Director, CIHR Centre for REACH 2.0 in HIV/AIDS Director, CIHR Collaborative Centre for
More informationBinge drinking decreases weekend adherence in a RCT from low and middle income countries
Binge drinking decreases weekend adherence in a RCT from low and middle income countries Raquel B. De Boniᵃ Lu Zhengᵇ, Susan Rosenkranzᵇ, Xin Sunᵇ, Sandra Wagnerᵃ, Beatriz Grinsztejnᵃ, Alberto La Rosaᶜ,
More informationHIV and alcohol use: why is risk reduction in alcohol use important in HIV care?
HIV and alcohol use: why is risk reduction in alcohol use important in HIV care? Susanne Astrab Fogger, DNP, PMHNP-BC, CARN-AP, FAANP sfogger@uab.edu Objectives for today s session Define alcohol use disorder
More informationThe Relationship Between Alcohol Use and HIV in MSM
The Relationship Between Alcohol Use and HIV in MSM Frederick L. Altice, M.D., M.A. Director of Clinical and Community Research Professor of Medicine and Public Health Yale University 0 Disclosures and
More informationAlcohol consumption and the intention to engage in unprotected sex: systematic review and meta-analysis of experimental studiesadd_
REVIEW doi:10.1111/j.1360-0443.2011.03621.x Alcohol consumption and the intention to engage in unprotected sex: systematic review and meta-analysis of experimental studiesadd_3621 51..59 Jürgen Rehm 1,2,3,
More informationALCOHOL & HIV IN SUB-SAHARAN AFRICA: SITUATIONAL ANALYSIS
ALCOHOL & HIV IN SUB-SAHARAN AFRICA: SITUATIONAL ANALYSIS health Department: Health REPUBLIC OF SOUTH AFRICA Situational Analysis on Alcohol and HIV in Sub Saharan Africa: Findings and Recommendations
More informationAlcohol & Drug Abuse Research Unit, Medical Research Council, and Department of Psychiatry, Stellenbosch University, Cape Town, South Africa 2
African Journal of Drug & Alcohol Studies, 9(2), 2010 Copyright 2010, CRISA Publications IS THERE A CAUSAL RELATIONSHIP BETWEEN ALCOHOL AND HIV? IMPLICATIONS FOR POLICY, PRACTICE AND FUTURE RESEARCH Charles
More informationClinical and Behavioral Characteristics of HIV-infected Young Adults in Care in the United States
Clinical and Behavioral Characteristics of HIV-infected Young Adults in Care in the United States Linda Beer, PhD, Christine L. Mattson, PhD, Joseph Prejean, PhD, and Luke Shouse, MD 10 th International
More informationWe are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists. International authors and editors
We are IntechOpen, the world s leading publisher of Open Access books Built by scientists, for scientists 3,800 116,000 120M Open access books available International authors and editors Downloads Our
More informationAIDS-RELATED STIGMA, HIV TESTING, AND TRANSMISSION RISK IN CAPE TOWN, SOUTH AFRICA
AIDS-RELATED STIGMA, HIV TESTING, AND TRANSMISSION RISK IN CAPE TOWN, SOUTH AFRICA Eileen V. Pitpitan, Ph.D. Center for Health, Intervention, and Prevention, University of Connecticut Annual Meeting of
More informationWhen PrEP fails. Laura Waters MD FRCP Mortimer Market Centre London
When PrEP fails Laura Waters MD FRCP Mortimer Market Centre London www.aidsunited.org PrEP works If people at risk take it If it s taken in the right way If it s available Commissioned/licensed Affordable
More informationPhaphama interventions to reduce both alcohol use and HIV/STI risks
Phaphama interventions to reduce both alcohol use and HIV/STI risks Presenter: Prof Leickness C. Simbayi, D.Phil. Executive Director, Social Aspects of HIV/AIDS and Health, Human Sciences Research Council,
More informationUnderstanding contraceptive choices among a cohort of HIV-positive women
Understanding contraceptive choices among a cohort of HIV-positive women Malika Sharma, MD FRCPC with Blitz S, Walmsley S, Raboud J, Money D for the CTN 236 investigators January 13, 2014 Conflict of Interest
More informationHIV care engagement among people with a history of injection drug use
HIV care engagement among people with a history of injection drug use Ann N. Burchell, PhD Scientist, Dept of Family and Community Medicine and Li Ka Shing Knowledge Institute St. Michael s Hospital burchella@smh.ca
More informationMotivational Interviewing in MMT
Motivational Interviewing in MMT 2015 Ontario Methadone Prescribers Conference November 6 th, 2015 8:30 am 9:15 am Dr. Peter Selby, MBBS, CCFP, FCFP, MHSc, dipabam Professor, DFCM, Psychiatry and the Dalla
More informationUsing a validated computer simulation to assess HIV prevention efforts in Connecticut
Using a validated computer simulation to assess HIV prevention efforts in Connecticut R. Scott Braithwaite, MD, MS, FACP Professor of Medicine and Population Health CIRA/Yale and New York University Introduction
More informationRevised 8/19/14 1. M.A., Statistics (2010) University of Michigan, Ann Arbor, MI
Revised 8/19/14 1 JENNIFER L. WALSH Centers for Behavioral and Preventive Medicine The Miriam Hospital Coro West, Suite 309, 164 Summit Ave Providence, RI 02906 Departments of Psychiatry and Human Behavior
More informationFactors associated with unsuppressed viral load in HIV-1 infected patients on 1 st line antiretroviral therapy in South Africa
Factors associated with unsuppressed viral load in HIV-1 infected patients on 1 st line antiretroviral therapy in South Africa Dvora Joseph Davey 1, 2, PhD, Zulfa Abrahams 2, PhD 1 BroadReach, South Africa
More informationAddressing Mental Health in HIV Prevention and Treatment Research Kathleen J. Sikkema, Ph.D.
Addressing Mental Health in HIV Prevention and Treatment Research Kathleen J. Sikkema, Ph.D. Professor of Psychology and Neuroscience, Global Health, and Psychiatry and Behavioral Sciences Director, Social
More informationALCOHOL AND HIV/AIDS
ALCOHOL AND HIV/AIDS 1 Addressing alcohol problems for improved HIV/AIDS response The pervasive HIV/AIDS epidemic presents a major challenge to poverty eradication and development in many low- and middle-income
More informationHIV In South Africa: Turning the Tide of the Epidemic
HIV In South Africa: Turning the Tide of the Epidemic Jean B. Nachega, MD, PhD Associate Professor Department of Epidemiology Pittsburgh University, Graduate School of Public Health E-mail: JBN16@PITT.EDU
More informationDr. Madhombiro. Department of Psychiatry UZ College of Health Sciences
Dr. Madhombiro Department of Psychiatry UZ College of Health Sciences Alcohol and substance use and ART Adherence I have no actual or potential conflicts to declare in relation to this programme and presentation
More informationCommunity-Level HIV Prevention Trials: Design, Implementation and Effectiveness
Community-Level HIV Prevention Trials: Design, Implementation and Effectiveness Kathleen J. Sikkema, Ph.D. Duke University Professor of Psychology and Neuroscience Research was supported by grant R01-MH42908
More informationCommunity-Based TasP Trials: Updates and Projected Contributions. Reaching the target: Lessons from HPTN 071 (PopART) Sarah Fidler
Community-Based TasP Trials: Updates and Projected Contributions Reaching the 90-90-90 target: Lessons from HPTN 071 (PopART) Sarah Fidler Cascade of Care: Sub-Saharan Africa HIV test +ve in past 12 m
More informationRESEARCH ARTICLES Increasing problem of alcohol abuse among the Zambian population in the psychiatric setting
RESEARCH ARTICLES Increasing problem of alcohol abuse among the Zambian population in the psychiatric setting N von Hammerstein 1, R Paul 2, J Ncheka 2 1. International Psychoanalytic University, Berlin,
More informationQ and A - the PARTNER Study: new results from PARTNER 2
Q and A - the PARTNER Study: new results from PARTNER 2 1. Study results What is the PARTNER Study? The PARTNER study is an international two-phase study that looked at whether HIV transmission occurs
More informationLessons from MSM PrEP pilots / demonstration projects. Kevin Rebe
Lessons from MSM PrEP pilots / demonstration projects Kevin Rebe rebe@anovahealth.co.za PrEP Demonstration Projects US: Multisite demonstration project in San Francisco, Miami and Washington DC. South
More informationPaediatric and Adolescent HIV Research Grant Programme
Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Paediatric and Adolescent HIV Research Grant Programme Call for Letter of Intent Table of Contents I. GRANT INFORMATION... 2
More informationIllicit substance use among MSM and HIV in South America
Illicit substance use among MSM and HIV in South America Raquel B. De Boni, MD, MsC, PhD Instituto National de Infectologia Evandro Chagas/ FIOCRUZ Rio de Janeiro-Brazil HPTN Regional Meeting Lima, 2018
More informationAdherence and HIV Suppression after Behavioral Intervention in Patients with Elevated Viral Load
Adherence and HIV Suppression after Behavioral Intervention in Patients with Elevated Viral Load Neil Schneiderman University of Miami For the MACH 14 Investigators IAPAC Miami Beach, FL June 5, 2012 #79993
More informationETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF
ETHICS IN HIV PREVENTION RESEARCH IN THE NEW ERA OF PrEP MTN Regional Meeting Cape Town 20 September 2017 Dhevium Govender South African Medical Research Council HIV Prevention Research Unit Quality/Regulatory
More informationSANCA DURBAN ALCOHOL AND DRUG CENTRES
STEERING COMMITTEE MEETING : DEVELOPING SERVICE QUALITY MEASURES FOR SUBSTANCE ABUSE IN SOUTH AFRICA LAGOON BEACH HOTEL, CAPE TOWN 25-26 NOVEMBER 2008 INTEGRATING HIV ISSUES INTO DRUG TREATMENT SERVICES
More informationState of the Art for ART for Prevention. Wafaa El-Sadr, MD, MPH ICAP-Columbia University
State of the Art for ART for Prevention Wafaa El-Sadr, MD, MPH ICAP-Columbia University Millions Global Scale-Up of HIV Treatment 4.5 4.0 3.5 3.0 2.5 2.0 1.5 1.0 0.5 End of 2002 End of 2003 End of 2004
More informationAlcohol use and women with and at risk for HIV. Geetanjali Chander & Heidi Hutton
Alcohol use and women with and at risk for HIV Geetanjali Chander & Heidi Hutton Disclosures None FFR1.05 Current, Binge, and Heavy Alcohol Use among People Aged 12 or Older: 2017 Note: Since 2015, the
More informationState of Alabama HIV Surveillance 2013 Annual Report Finalized
State of Alabama HIV Surveillance 2013 Annual Report Finalized Prepared by: Division of STD Prevention and Control HIV Surveillance Branch Contact Person: Allison R. Smith, MPH Allison.Smith@adph.state.al.us
More informationState of Alabama HIV Surveillance 2014 Annual Report
State of Alabama HIV Surveillance 2014 Annual Report Prepared by: Division of STD Prevention and Control HIV Surveillance Branch Contact Person: Richard P. Rogers, MS, MPH richard.rogers@adph.state.al.us
More informationPrevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers)
Prevention and care towards vulnerable and stigmatized populations (MSM, drug users, sex workers) Joseph LARMARANGE - CEPED/IRD Symposium ANRS - AIDS 2012-23 July 2012 Epidemiological context» South America
More informationShebeens offer opportunity for HIV testing among high risk young men and women
Shebeens offer opportunity for HIV testing among high risk young men and women South African AIDS Conference Durban 14 June 2017 Dr S Shenoi / Dr. Tony Moll Shebeens Informal or formal drinking venue for
More informationCopyright 2016 Social and Epidemiological Research Department, Centre for Addic on and Mental Health (CAMH).
2014 W P F S, D A S S F : O R Copyright 2016 Social and Epidemiological Research Department, Centre for Addic on and Mental Health (CAMH). For addi onal informa on, please contact: Paul Shuper, Ph.D. Senior
More informationTowards universal access
Key messages Towards universal access Scaling up priority HIV/AIDS interventions in the health sector September 2009 Progress report Towards universal access provides a comprehensive global update on progress
More informationAddiction, health and treatment interventions
Addiction, health and treatment interventions J. Rehm Social and Epidemiological Research (SER) Department, Centre for Addiction and Mental Health, Toronto, Canada Dalla Lana School of Public Health, University
More informationFocusing Our Efforts Ontario s Proposed HIV/AIDS Strategy to 2025
Focusing Our Efforts Ontario s Proposed HIV/AIDS Strategy to 2025 Frank McGee, AIDS & Hepatitis C Programs Ontario Harm Reduction Conference 2015 October 26, 2015 Our successes! We are doing well in Ontario
More informationThe CQUIN Learning Network
The CQUIN Learning Network Adolescents Living with HIV: Innovations and Experience Shenaaz Pahad Wits Reproductive Health and HIV Institute October 24-27, 2017 Johannesburg, South Africa Why adolescents
More informationALCOHOL S BURDEN (with special attention to Africa and the NCDs)
ALCOHOL S BURDEN (with special attention to Africa and the NCDs) Isidore S. Obot, PhD, MPH Professor of Psychology, University of Uyo Director, Centre for Research and Information on Substance Abuse (CRISA),
More informationChoosing the right study design
Choosing the right study design Main types of study design Randomised controlled trial (RCT) Cohort study Case-control study Cross-sectional study Case series/case note review Expert opinion BEST QUALITY
More informationPennsylvania Department of Health 2003 Behavioral Risks of McKean County Adults Page 1
2003 Behavioral Health Risks Of Adults Collaborative Board Pennsylvania Department of Health 2003 Behavioral Risks of Adults Page 1 Introduction The Centers for Disease Control and Prevention (CDC) and
More informationThe epidemiology of HIV in Canada
FACTSHEET The epidemiology of HIV in Canada This fact sheet provides a snapshot of the HIV epidemic in Canada. It is one of a series of fact sheets on the epidemiology of HIV and hepatitis C in Canada.
More informationAn Analysis of NIMH HIV/AIDS Prevention Research Funding
THE AIDS INSTITUTE An Analysis of NIMH HIV/AIDS Prevention Research Funding Emily McCloskey, Public Policy Associate Carl Schmid, Deputy Executive Director United States Conference on AIDS Orlando, FL
More informationFresh Perspectives on the Alcohol and HIV Nexus: A Call for Action in an Era of Increased Opportunities and Challenges
DOI 10.1007/s10461-017-1917-0 EDITORIAL Fresh Perspectives on the Alcohol and HIV Nexus: A Call for Action in an Era of Increased Opportunities and Challenges Charles D. H. Parry 1,2 Mark Tomlinson 3 Kendall
More informationVictoria Pilkington, Andrew Hill, Sophie Hughes, Nneka Nwokolo and Anton Pozniak. Pilkington et al. Glasgow HIV Poster 0143
Victoria Pilkington, Andrew Hill, Sophie Hughes, Nneka Nwokolo and Anton Pozniak 36.7 Million 1.8 Million 1 Million NEW INFECTIONS LIVING WITH HIV DEATHS https://www.avert.org/global-hiv-and-aids-statistics.
More informationTable S1. Number of eligible individuals by cohort, HIV-CAUSAL and CNICS Collaborations,
Cohort Table S1. Number of eligible individuals by cohort, HIV-CAUSAL and CNICS Collaborations, 2000-2013 No. of antiretroviraltherapy naïve individuals No. initiated cart regimen in 2000 or later No.
More informationEngagement in group sex among geosocial networking (GSN) mobile application-using men who have sex with men (MSM)
City University of New York (CUNY) CUNY Academic Works Publications and Research CUNY School of Public Health 3-26-2015 Engagement in group sex among geosocial networking (GSN) mobile application-using
More informationSINDAWONYE Clinical Trials Unit
HIV PREVENTION RESEARCH UNIT SINDAWONYE Clinical Trials Unit (we are together) GITA RAMJEE MTN Regional Meeting, Cape Town, South Africa 21-24 May 2007 CHATSWORTH CRS POPULATION CHARACTERISTICS CHATSWORTH
More informationWhere are we going after effectiveness studies?
Where are we going after effectiveness studies? Nyaradzo M. Mgodi (MBChB, MMed) UZ-UCSF Collaborative Research Program Harare, Zimbabwe MTN Annual Meeting 28 March 2011, Arlington, VA Introduction 30 years
More informationWhat the AMPHORA project says for European alcohol policy
AMPHORA NEWSLETTER DECEMBER 2012 What the AMPHORA project says for European alcohol policy Potential impact The main outcomes of the scientific work of the AMPHORA project drive the need for stepped-up
More informationDisparities in HIV Care. Slides prepared by Kirk Fergus, Intern National Quality Center
Disparities in HIV Care Slides prepared by Kirk Fergus, Intern National Quality Center At a glance At a glance MSM accounted for 61% of all new HIV infections in the U.S. in 2009, as well as nearly half
More informationArresting HIV in Malawi prisons
Arresting HIV in Malawi prisons Implementation of the HIV test-and-treat strategy in Malawi prisons: experience, challenges, and effectiveness Mendelsohn S 1, Aluda C 1, Ortuno R 1, Shigayeva A 1, Hilderbrand
More informationCopyright 2016 Social and Epidemiological Research Department, Centre for Addic on and Mental Health (CAMH).
2014 W P F S, D A S S F Copyright 2016 Social and Epidemiological Research Department, Centre for Addic on and Mental Health (CAMH). For addi onal informa on, please contact: Paul Shuper, Ph.D. Senior
More informationPsychosocial Issues in ART and HIV Prevention. Steven A. Safren, PhD
Psychosocial Issues in ART and HIV Prevention Steven A. Safren, PhD MSM, Mental Health, and Sexual Health 1. Why is behavioral science important when using ART as prevention? 2. How can we address the
More information2016 NYS HIV Quality of Care Review
2016 NYS HIV Quality of Care Review A new way forward in four parts Bruce Agins, MD, MPH Medical Director NYSDOH AIDS Institute December 15, 2016 Ending the Epidemic: update! A 3-Point plan announced by
More informationGay Poz Sex (GPS): Qualitative findings of a Community-Based Counselling Intervention for HIV- Positive Gay and Bisexual Men
Gay Poz Sex (GPS): Qualitative findings of a Community-Based Counselling Intervention for HIV- Positive Gay and Bisexual Men Trevor A. Hart 1,2, Barry Adam 3,4, Natalie Stratton 1, John Maxwell 5, Robert
More informationLessons Learned: Community Mobilization & the HIV-Positive Sero-Status Disclosure Intervention
Mobilizing Across Canada to Build Effective Responses to HIV in African, Caribbean, and Black Communities June 8 th, 2016 AOHC 2016 Lessons Learned: Community Mobilization & the HIV-Positive Sero-Status
More informationEnd AIDS: The HIV Prevention & Outreach Summit Call for Workshop Submissions
End AIDS: The HIV Prevention & Outreach Summit Call for Workshop Submissions What is End AIDS: The HIV Prevention & Outreach Summit? End AIDS: The HIV Prevention and Outreach Summit is a conference that
More informationPrEP: Pre Exposure Prophylaxis
PrEP: Pre Exposure Prophylaxis Lyn Stevens, NP, MS, ACRN Deputy Director Office of the Medical Director NYS Department of Health, AIDS Institute Faculty Disclosure Lyn Stevens No relationships to disclose
More informationOn-going Integrated Strategy Interventions to Maximize ART and PrEP Effectiveness in Peru
On-going Integrated Strategy Interventions to Maximize ART and PrEP Effectiveness in Peru Dr. Javier R. Lama Investigator and Director, HIV Prevention Intervention Studies IMPACTA PERU Clinical Trials
More informationTranslating Science to end HIV in Latin America and the Caribbean
Translating Science to end HIV in Latin America and the Caribbean Mexico City, Mexico, 17 th - 18 th and 21 st April www.iasociety.org IAS 2017 post-conference workshop, 17 April 2018 Challenges for PrEP
More informationA Sex-informed Framework for HIV Prevention. Robert M. Grant, M.D., M.P.H. Betty Jean and Hiro Ogawa Endowed Investigator
A Sex-informed Framework for HIV Prevention Robert M. Grant, M.D., M.P.H. Betty Jean and Hiro Ogawa Endowed Investigator Disclosures Gilead Sciences donated study medication to US NIH for trials that I
More informationDesigning Evidence-Based HIV/STD Interventions for African American Youth
Toronto I-II 11:45 am Designing Evidence-Based HIV/STD Interventions for African American Youth Loretta Jemmott van AmeringenProfessor in Psychiatric Mental Health Nursing, Director of the Center for Health
More informationCollege Drinking Outcomes: A Role for the Alcohol Environment
College Drinking Outcomes: A Role for the Alcohol Environment Richard Scribner MD, MPH LSU Health Sciences Center NEW ORLEANS School of Public Health Acknowledgements Funding NIAAA R01 AA014679 Research
More informationHIV drug resistance and tracing outcomes among antiretroviral therapy defaulters in Malawi
HIV drug resistance and tracing outcomes among antiretroviral therapy defaulters in Malawi Bello G 1, ParkinN 2, KagoliM 1, ChipetaS 1, CzaickiN 3, Pry J 3, OdenyT 3, NyasuluI 4, LapointeH 5, Doherty M
More informationincreased efficiency. 27, 20
Table S1. Summary of the evidence on the determinants of costs and efficiency in economies of scale (n=40) a. ECONOMETRIC STUDIES (n=9) Antiretroviral therapy (n=2) Scale was found to explain 48.4% of
More informationNegative affect words prime beer consumption in young drinkers
Addictive Behaviors 31 (2006) 169 173 Short communication Negative affect words prime beer consumption in young drinkers Martin Zack a, *, Constantine X. Poulos a, Fofo Fragopoulos a, Tracy M. Woodford
More informationTaking an adherence intervention from efficacy to effectiveness
Toronto I-II 8:30 pm Taking an adherence intervention from efficacy to effectiveness Jeffrey Parsons Editor of Sexuality Research and Social Policy, Associate Editor of Archives of Sexual Behavior and
More informationDRUG USE AMONG ONTARIO STUDENTS Highlights from the Ontario Student Drug Use and Health Survey (OSDUHS) January 31, :30am-12pm
DRUG USE AMONG ONTARIO STUDENTS Highlights from the Ontario Student Drug Use and Health Survey (OSDUHS) January 31, 2018 10:30am-12pm 1 About the Provincial System Support Program (PSSP) Supports Ontario
More informationBehavioral Research in the Microbicide Trials Network
Behavioral Research in the Microbicide Trials Network HANC Behavioral Sciences Working Group Symposium Miami June 8, 2014 Ariane van der Straten, PhD, MPH Member, MTN Behavioral Research Working Group
More informationEvidence-based ART adherence. Dr Catherine Orrell Desmond Tutu HIV Foundation 26 November 2012
Evidence-based ART adherence Dr Catherine Orrell Desmond Tutu HIV Foundation 26 November 2012 What is adherence? There are two main components: 1) Adherence to daily treatment All tablets taken At the
More informationPREVENTION OF HCV IN PEOPLE WHO INJECT DRUGS
PREVENTION OF HCV IN PEOPLE WHO INJECT DRUGS Holly Hagan, PhD Professor Co-Director, Center for Drug Use and HIV Research Principal Investigator, HCV Synthesis Project New York University HCV prevalence
More informationHIV and adolescents: guidance for HIV testing and counselling and care for adolescents living with HIV
WHO/HIV/2013.131 World Health Organization 2013 HIV and adolescents: guidance for HIV testing and counselling and care for adolescents living with HIV ANNEX 6: GRADE Evidence profiles GRADE evidence profiles:
More informationPREVENTION STRATEGIES RELATED TO HIV/AIDS Narra Smith Cox, Ph.D., CHES
PREVENTION STRATEGIES RELATED TO HIV/AIDS Narra Smith Cox, Ph.D., CHES Background In Wisconsin the two primary modes of HIV transmission are unsafe sexual behavior and nonsterile injection practices. More
More informationAdherence to ART in HIV-infected children in Kenya, South Africa, and Thailand
Adherence to ART in HIV-infected children in Kenya, South Africa, and Thailand Rachel C. Vreeman, MD, MS Director of Research, IU Center for Global Health Associate Professor of Pediatrics Indiana University
More informationClinical and Public Health Policy Implications of Findings that:
Clinical and Public Health Policy Implications of Findings that: Adherence to HIV Medications and Emotional/Physiological Coping with Stress are Independently Associated with Specific Five-Year Outcome
More informationFrom to zero new infections, zero deaths, reduced stigma
From 95-95-95 to zero new infections, zero deaths, reduced stigma Ambassador Deborah Birx IAS July 2018 #PEPFAR15 Moving from generic to specific Moving from words to action Holding ourselves accountable
More informationNew England HIV Implementation Science Network
Common Interests/Questions/Discussion Points across the Network Work Groups Identified In the First and Second Web Meeting Summaries (December 2014 January 2015) Key population: men who have sex with men
More informationAnna Maria Geretti on behalf of co-authors Professor of Virology & Infectious Diseases, University of Liverpool Expert Scientist, Roche Pharma
Anna Maria Geretti on behalf of co-authors Professor of Virology & Infectious Diseases, University of Liverpool Expert Scientist, Roche Pharma Research & Early Discovery Funding: Wellcome Trust, National
More informationDidactic Series. How Psychosocial Syndemics Perpetuate the HIV Epidemic
Didactic Series How Psychosocial Syndemics Perpetuate the HIV Epidemic David J. Grelotti, MD University of California, San Diego November 10, 2016 dgrelotti@ucsd.edu 1 Disclosures Pharmaceutical industry:
More informationBurden and cost of alcohol, tobacco and illegal drugs globally and in Europe
Burden and cost of alcohol, tobacco and illegal drugs globally and in Europe Jürgen Rehm 1-4 Kevin D. Shield 1,2,3 1) Centre for Addiction and Mental Health, Toronto, Canada 2) University of Toronto, Canada
More informationPre-Exposure Prophylaxis (PrEP) A Biomedical Intervention Prevention with Negatives Antiretroviral Prevention
Pre-Exposure Prophylaxis (PrEP) A Biomedical Intervention Prevention with Negatives Antiretroviral Prevention New and Emerging Biomedical HIV Prevention Interventions Vaccines Vaginal microbicides Pre-exposure
More informationFull Name of Training Program TEACH: Training Enhancement in Applied Cessation Counselling and Health
ATTUD APPLICATION FORM FOR WEBSITE LISTING (PHASE 1): TOBACCO TREATMENT SPECIALIST (TTS) TRAINING PROGRAM APPLICATION NUMBER: TTS 2008_5_ 0003 PROGRAM INFORMATION & OVERVIEW Date of this Application May
More informationDate of study period: April 12 May 7, 2010 and August September, 2010
Classification of antiretroviral therapy failure using immunologic and clinical versus virologic monitoring in HIV-infected children and adolescents in Cambodia Date of study period: April 12 May 7, 2010
More informationNIH Public Access Author Manuscript Alcohol Res Health. Author manuscript; available in PMC 2012 March 19.
NIH Public Access Author Manuscript Published in final edited form as: Alcohol Res Health. 2011 ; 34(2): 135 143. The Risks Associated With Alcohol Use and Alcoholism Jürgen Rehm, Ph.D. Director of the
More informationTreatment as prevention (TasP) Can treatment reduce the transmission of HIV: Experience from the UK
Treatment as prevention (TasP) Can treatment reduce the transmission of HIV: Experience from the UK Dr Valerie Delpech Health Protection Agency, London (Public Health England) Outline! Brief overview Science,
More informationSmoking Cessation In Patients With Substance Use Disorders: The Vancouver Coastal Health Tobacco Dependence Clinic
University of Kentucky From the SelectedWorks of Chizimuzo T.C. Okoli July, 2010 Smoking Cessation In Patients With Substance Use Disorders: The Vancouver Coastal Health Tobacco Dependence Clinic Milan
More informationThe Association Between Alcohol Consumption and Condom Use: Considering Correlates of HIV Risk Among Black Men Who Have Sex with Men
DOI 10.1007/s10461-015-1075-1 SUBSTANTIVE REVIEW The Association Between Alcohol Consumption and Condom Use: Considering Correlates of HIV Risk Among Black Men Who Have Sex with Men Vincent C. Allen Jr.
More informationBarriers and facilitators to routine HIV testing among Massachusetts community health centers:
Barriers and facilitators to routine HIV testing among Massachusetts community health centers: An example of Community-Based Participatory Research Carey V. Johnson, ScM Study Coordinator The Fenway Institute
More informationAbout FEM-PrEP. FEM-PrEP is also studying various behaviors, clinical measures, and health outcomes among the trial s participants.
Fact Sheet About FEM-PrEP What is the FEM-PrEP clinical trial? FEM-PrEP is a Phase III randomized, placebo-controlled, clinical trial designed to assess the safety and effectiveness of a daily oral dose
More informationThirty years of harm reduction in the Netherlands HCV elimination ahead?
Thirty years of harm reduction in the Netherlands HCV elimination ahead? Esther Croes, MD PhD Confession 30 years 3 topics: drug use, harm reduction, HCV in 15 minutes IT DOESN T FIT!! 2 Disclosure Esther
More informationEvidence-based Strategies to Address Retention in HIV Care
Evidence-based Strategies to Address Retention in HIV Care Philip A. Chan, MD, MS Rhode Island Department of Health, Providence, Rhode Island Brown University, Providence, Rhode Island Capacity Building
More informationCharacteristics of Transgender Women Living with HIV Receiving Medical Care in the United States
LGBT Health Volume 2, Number 00, 2015 ª Mary Ann Liebert, Inc. DOI: 10.1089/lgbt.2014.0099 ORIGINAL ARTICLE Characteristics of Transgender Women Living with HIV Receiving Medical Care in the United States
More informationDisclosure. Learning Objectives. Epidemiology. Transmission. Risk of Transmission PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV PREVENTION 50,000.
Disclosure PRE-EXPOSURE PROPHYLAXIS (PREP) FOR HIV PREVENTION I have no financial interest in and/or affiliation with any external organizations in relation to this CE program. DaleMarie Vaughan, PharmD
More information